- Report
- October 2025
- 197 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- October 2025
- 276 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- September 2025
- 250 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1431EUR$1,600USD£1,259GBP
€1789EUR$2,000USD£1,574GBP
- Report
- June 2025
- 135 Pages
Global
From €3687EUR$4,123USD£3,244GBP
€4338EUR$4,850USD£3,816GBP
- Report
- October 2023
- 75 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- May 2024
- 134 Pages
Global
From €4941EUR$5,524USD£4,346GBP
€5813EUR$6,499USD£5,113GBP
- Report
- May 2022
- 38 Pages
Global
From €1789EUR$2,000USD£1,574GBP
- Report
- January 2024
- 200 Pages
Global
From €3712EUR$4,150USD£3,265GBP
- Clinical Trials
- January 2021
- 60 Pages
Global
From €1073EUR$1,200USD£944GBP
€1342EUR$1,500USD£1,180GBP
- Report
- May 2023
- 133 Pages
Global
From €3500EUR$4,192USD£3,186GBP
Vaginitis Drug is a type of drug used to treat vaginitis, a condition characterized by inflammation of the vagina. Vaginitis is caused by a variety of factors, including bacterial, fungal, and viral infections, as well as hormonal imbalances. Vaginitis Drugs are used to treat the symptoms of vaginitis, such as itching, burning, and discharge. They may also be used to treat the underlying cause of the condition. Vaginitis Drugs are part of the larger Sexual and Reproductive Health Drugs market, which includes drugs used to treat a variety of conditions related to sexual and reproductive health, such as contraception, infertility, and sexually transmitted infections.
Some companies in the Vaginitis Drug market include Pfizer, Merck, GlaxoSmithKline, Bayer, and Novartis. Show Less Read more
